Publicaciones (22) Publicaciones de María Ester González Sánchez

2024

  1. Experimental Model of Biliary Tract Cancers: Subcutaneous Xenograft of Human Cell Lines in Immunodeficient Nude Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 87-98

2023

  1. Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

    Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480

  2. Intrinsic cancer cell phosphoinositide 3-kinase δ regulates fibrosis and vascular development in cholangiocarcinoma

    Liver International, Vol. 43, Núm. 12, pp. 2776-2793

  3. Protective potential of the gallbladder in primary sclerosing cholangitis

    JHEP Reports, Vol. 5, Núm. 4

2022

  1. Genetic alterations shaping tumor response to anti-EGFR therapies

    Drug Resistance Updates, Vol. 64

  2. Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis

    Hepatology, Vol. 76, Núm. 5, pp. 1360-1375

2021

  1. Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1867, Núm. 4

  2. NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice

    Redox Biology, Vol. 40

  3. The tgf-β pathway: A pharmacological target in hepatocellular carcinoma?

    Cancers, Vol. 13, Núm. 13

  4. Zinc Finger E-Box Binding Homeobox 1 Promotes Cholangiocarcinoma Progression Through Tumor Dedifferentiation and Tumor–Stroma Paracrine Signaling

    Hepatology, Vol. 74, Núm. 6, pp. 3194-3212

2020

  1. Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma

    Cancers, Vol. 12, Núm. 5

2017

  1. Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1863, Núm. 7, pp. 1699-1708

2016

  1. Protective role of biliverdin against bile acid-induced oxidative stress in liver cells

    Free Radical Biology and Medicine, Vol. 97, pp. 466-477

2015

  1. E-cadherin, guardian of liver physiology

    Clinics and Research in Hepatology and Gastroenterology, Vol. 39, Núm. 1, pp. 3-6

  2. Nuclear receptors in acute and chronic cholestasis

    Digestive Diseases

2014

  1. Liver metabolic/oxidative stress induces hepatic and extrahepatic changes in the expression of the vitamin C transporters SVCT1 and SVCT2

    European Journal of Nutrition, Vol. 53, Núm. 2, pp. 401-412

  2. The effect of acetaminophen on the expression of BCRP in trophoblast cells impairs the placental barrier to bile acids during maternal cholestasis

    Toxicology and Applied Pharmacology, Vol. 277, Núm. 1, pp. 77-85

  3. The expression of genes involved in hepatocellular carcinoma chemoresistance is affected by mitochondrial genome depletion

    Molecular Pharmaceutics, Vol. 11, Núm. 6, pp. 1856-1868

2013

  1. Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: Role of the Akt/mTOR survival pathway and Bcl-2 family proteins

    Free Radical Biology and Medicine, Vol. 61, pp. 218-228

2012

  1. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins

    Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576